SELECT Trial Data Show Benefit of Semaglutide in Patients With Obesity

The SELECT trial expands on existing literature that have shown safety and cardiovascular benefit in individuals with diabetes to now also show benefit in obesity.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,American ,Aniam Jastreboff , ,Novo Nordisk ,Yale School Of Medicine ,American Heart Association ,Yale School ,Scientific Sessions ,